logo

Therapix Biosciences Ltd. (TRPX)



Trade TRPX now with
  Date
  Headline
7/31/2019 9:29:47 AM Therapix Biosciences Announces Canadian Product License Issuance For TheraPEA
7/5/2019 3:54:44 AM Therapix Biosciences Posts Q1 Net Loss Of $2.14 Mln
6/18/2019 9:32:12 AM Therapix : THX-110 Positively Affects Symptoms In Adult Subjects With Obstructive Sleep Apnea
3/28/2019 8:37:57 AM Therapix Biosciences Announces Pricing Of $2.25 Mln Registered Direct Offering
3/19/2019 6:31:39 AM Therapix Biosciences Appoints Ron Prosor As Executive Advisor
12/21/2018 8:33:46 AM Therapix Biosciences Terminates FSD Acquisition LoI
10/24/2018 6:03:23 AM Therapix Biosciences Signs Binding LOI To Be Acquired By FSD Pharma For $48 Mln
8/20/2018 8:36:08 AM Therapix Biosciences Q2 Net Loss Of $1.2 Mln Or $0.35/ADS Vs Loss Of $1.86 Mln Or $1.10/ADS Last Year
7/17/2018 8:34:39 AM Therapix Biosciences Announces Positive Data From Recent Pre-clinical Studies For Drug Candidate THX-160 For Pain
7/11/2018 8:58:29 AM Cure Pharma Signs Term Sheet To Acquire Non-pain Assets Of Therapix